Table 2 Relationship between of CAMK2A expression and clinical characteristics of patients with CESC
Gene | Characteristics | Total (N) | Odds ratio (OR) | P value |
|---|---|---|---|---|
CAMK2A | Age (≤ 50 vs. > 50) | 304 | 1.657 (0.992–2.910) | 0.064 |
BMI (≤ 25 vs. > 25) | 259 | 2.047 (1.196–3.624) | 0.011 | |
Menopause status (Pre vs. Peri and Post) | 231 | 1.885 (1.070–3.519) | 0.035 | |
Histological type (adenosquamous vs. squamous cell carcinoma) | 304 | 0.008 (0.001–0.057) |  < 0.001 | |
T stage (T1 and T2 vs. T3 and T4) | 241 | 0.692 (0.356–1.475) | 0.301 | |
N stage (N0 vs. N1) | 193 | 0.914 (0.496–1.753) | 0.777 | |
M stage (M0 vs. M1) | 126 | 1.711 (0.441–14.791) | 0.534 | |
Clinical stage (stage I and stage II vs. stage IV and stage III) | 297 | 0.873 (0.512–1.558) | 0.629 | |
Histologic grade (G1 and G2 vs. G4 and G3) | 272 | 1.382 (0.810–2.441) | 0.246 | |
Primary therapy outcome (SD and PR and CR vs. PD) | 217 | 0.792 (0.347–2.149) | 0.607 | |
Radiation therapy (yes vs. no) | 304 | 0.803 (0.497–1.298) | 0.366 |